UP!

AERI $11.21   View long term graphs

Aerie Pharmaceuticals (NASDAQ: AERI) is a publicly traded, clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye. Aerie's two lead product candidates are once-daily IOP-lowering therapies with novel mechanisms of action to treat patients with glaucoma or ocular hypertension.

Q reports

Period Date Adjusted Actuals EPS GAAP EPS
Q3 2020 2020-11-09 Future report Set alerts
Q2 2020 2020-08-06 -0.83 -1.05
Q1 2020 2020-05-06 -0.83 -1.07
Q4 2019 2020-02-20 -0.96 -1.21
Q3 2019 2019-11-06 -0.86 -1.09
Q2 2019 2019-08-07 -0.80 -1.04
Q1 2019 2019-05-07 -0.78 -1.06
Q4 2018 2019-02-25 -0.92 -1.14
Q3 2018 2018-11-06 -1.73 -1.96
Q2 2018 2018-08-08 -1.14 -1.40

Ratings

2016-06-02 Initiated Coverage Cantor Fitzgerald Buy $44.00
2016-05-16 Reiterated Rating Brean Capital Buy
2016-05-03 Reiterated Rating Canaccord Genuity Buy
2016-05-03 Reiterated Rating Brean Capital Buy
2016-04-07 Reiterated Rating Brean Capital Buy
2016-03-19 Reiterated Rating Cantor Fitzgerald Buy $40.00
2016-03-19 Reiterated Rating Brean Capital Buy
2016-03-05 Reiterated Rating RBC Capital Buy
2016-03-05 Reiterated Rating Brean Capital Buy $48.00
2016-03-05 Reiterated Rating Royal Bank Of Canada Buy
2016-02-21 Reiterated Rating RBC Capital Outperform $50.00
2016-02-18 Reiterated Rating Canaccord Genuity Buy $44.00
2016-01-07 Reiterated Rating Brean Capital Buy $48.00
2015-12-02 Reiterated Rating Cantor Fitzgerald Buy $40.00
2015-11-05 Reiterated Rating Canaccord Genuity Buy $44.00
2015-11-04 Boost Price Target RBC Capital Outperform $44.00 to $50.00
2015-10-02 Reiterated Rating Brean Capital Buy
2015-09-17 Boost Price Target Cantor Fitzgerald Buy $30.00 to $40.00
2015-09-17 Boost Price Target Canaccord Genuity Buy $40.00 to $44.00
2015-09-17 Boost Price Target JMP Securities Outperform $39.00 to $49.00
2015-09-17 Boost Price Target Needham & Company LLC Buy $27.00 to $45.00
2015-09-17 Boost Price Target Brean Capital Buy $33.00 to $48.00
2015-09-17 Boost Price Target Stifel Nicolaus Buy $30.00 to $40.00
2015-09-17 Boost Price Target RBC Capital Outperform $31.00 to $44.00
2015-09-10 Reiterated Rating Brean Capital Buy $33.00
2015-09-09 Initiated Coverage JMP Securities Outperform $39.00
2015-08-06 Reiterated Rating Cantor Fitzgerald Buy $30.00
2015-08-06 Reiterated Rating Canaccord Genuity Buy $40.00
2015-08-06 Reiterated Rating Brean Capital Buy $33.00
2015-07-17 Boost Price Target Brean Capital Buy $24.00 to $33.00
2015-06-19 Upgrade Canaccord Genuity Hold to Buy $40.00
2015-06-16 Boost Price Target Cantor Fitzgerald Buy $15.00 to $30.00
2015-06-16 Boost Price Target RBC Capital Outperform $27.00 to $31.00
2015-06-16 Upgrade Needham & Company LLC Hold to Buy $13.27 to $27.00
2015-06-05 Reiterated Rating Piper Jaffray Buy $7.00 to $9.00
2015-06-05 Reiterated Rating Piper Jaffray Cos. Buy $7.00 to $9.00
2015-06-03 Reiterated Rating Brean Capital Buy $24.00
2015-06-02 Set Price Target Canaccord Genuity Hold $12.00
2015-05-08 Upgrade Cantor Fitzgerald Hold to Buy $15.00
2015-04-24 Downgrade Needham & Company LLC Buy to Hold
2015-04-24 Lower Price Target Stifel Nicolaus Buy $40.00 to $30.00
2015-04-24 Lower Price Target RBC Capital Outperform $50.00 to $27.00
2015-04-24 Downgrade Canaccord Genuity Buy to Hold $40.00 to $12.00
2015-04-24 Downgrade Cantor Fitzgerald Buy to Hold $12.00
2015-04-24 Lower Price Target Brean Capital Buy $46.00 to $24.00
2015-04-16 Boost Price Target RBC Capital Outperform $45.00 to $50.00
2015-03-25 Reiterated Rating Cantor Fitzgerald Buy $40.00
2015-03-24 Reiterated Rating MLV & Co. Buy $40.00
2015-03-24 Initiated Coverage Brean Capital Buy $46.00
2015-01-20 Reiterated Rating Canaccord Genuity Buy $40.00
2015-01-08 Reiterated Rating MLV & Co. Buy $40.00
2015-01-07 Initiated Coverage Cantor Fitzgerald Buy $40.00
2014-07-17 Boost Price Target RBC Capital Outperform $36.00 to $41.00
2014-07-03 Initiated Coverage Canaccord Genuity Buy $40.00
2014-06-26 Reiterated Needham Buy $26 to $37
2014-06-26 Boost Price Target RBC Capital Outperform $27.00 to $36.00
2014-06-26 Boost Price Target Needham & Company LLC Buy $26.00 to $37.00
2014-05-13 Lower Price Target RBC Capital Outperform $28.00 to $27.00
2014-03-19 Reiterated RBC Capital Mkts Outperform $25 to $28
2014-03-19 Reiterated Needham Buy $22 to $26
2014-03-19
2014-03-19 Boost Price Target Stifel Nicolaus Positive to Buy $22.00 to $24.00
2014-03-19 Boost Price Target RBC Capital Outperform $25.00 to $28.00
2014-03-19 Boost Price Target Needham & Company LLC Buy $22.00 to $26.00
2013-12-03 Initiated Coverage Needham & Company LLC Buy $18.00
2013-11-19 Initiated Stifel Buy $18
2013-11-19 Initiated RBC Capital Mkts Outperform $20
2013-11-19 Initiated Coverage Canaccord Genuity Buy to Buy $19.00
2013-11-19 Initiated Coverage RBC Capital Outperform $20.00
2013-11-19 Initiated Coverage Stifel Nicolaus Buy $18.00
2016-06-02 Initiated Coverage Cantor Fitzgerald Buy $44.00
2016-05-16 Reiterated Rating Brean Capital Buy
2016-05-03 Reiterated Rating Canaccord Genuity Buy
2016-05-03 Reiterated Rating Brean Capital Buy
2016-04-07 Reiterated Rating Brean Capital Buy

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Major Shareholders

Name Relationship Total Shares Holding stocks
Clarus Lifesciences II, L.P. 14.52%  (3468494) ACHN / AERI / NSTG / OPHT / TLOG /
TPG Group Holdings (SBS) Advisors, Inc. 8.74%  (2087466) AERI / ALDR / CDNA / CZR / EPRS / FSL / GPK / IMS / LPLA / MGNX / NCLH / NTI / OTIC / PKY / Q / ROKA / SABR / SCAI / SUP / TIPT / TMHC / TNDM / VCYT / ZMH /
Foresite Capital Management II, LLC 8.16%  (1950477) AERI /
ACP IV, L.P. 2.58%  (616099) AERI /
Mehra Anand 1.97%  (469591) AERI / MRNS /
RUBINO RICHARD J Chief Financial Officer 1.76%  (420293) AERI /
Kopczynski Casey C. Chief Scientific Officer 0.81%  (193061) AERI /
ANIDO VICENTE JR Chief Executive Officer 0.55%  (130777) AERI / DEPO /
MITRO THOMAS A President and COO 0.23%  (54296) AERI /
LaRocca John General Counsel 0.08%  (18000) AERI /
LEVY BRIAN Chief Medical Officer 0.07%  (16313) AERI /
Cagle Gerald D. 0.06%  (14050) AERI / CLSD /
GOLDBERG MURRAY A 0.02%  (4550) AERI / REGN /
MCGRAW BENJAMIN F III 0.02%  (4550) AERI /
DUYK GEOFFREY M 0.01%  (3400) AERI / AMRS / EPRS /
Croarkin Richard 0.01%  (2850) AERI / CLSD /
du Toit Michael 0.01%  (2850) AERI / EVDY /
McHugh Julie 0.01%  (2850) AERI / ENDP / EPRS / IRWD / LNTH / TRVN / VPHM /
GRYSKA DAVID W 0.01%  (1700) AERI / HPTX / INCY / PDLI / SGEN /

Comments